Utilizing Augmented Reality as an Adjunct for Smoking Cessation

Not Applicable

Completed

• Conditions: Smoking

• Registration Number: NCT04101422
• Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Brief Summary

The purpose of the study is to develop an preliminary test a tobacco smoking-related augmented reality (AR) paradigm for eventual development as an adjunctive tobacco cessation intervention.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-09-23
• Study First Submitted QC: 2019-09-23
• Study First Posted: 2019-09-24
• Study Start: 2019-10-07
• Primary Completion: 2022-02-14
• Study Completion: 2022-02-14
• Results First Submitted: 2023-02-06
• Status Verified: 2023-04
• Results First Submitted QC: 2023-04-26
• Last Update Submitted: 2023-04-26
• Results First Posted: 2023-05-22
• Last Update Posted: 2023-05-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 197

Inclusion Criteria

• Currently smoking ≥ 3 cigarettes per day for the past year
• Breath carbon monoxide (CO) level ≥ 5 ppm
• Motivated to quit smoking
• Aim 1 & 2 Only: Valid home address in the Tampa Bay area
• Functioning telephone number
• Can speak, read, and write in English
• Aim 3: Must have a smartphone that participant is willing to use during the study
• Aim 3: Motivated to quit smoking within the next month

Exclusion Criteria

• Regular use (e.g., no more than 1/3 of month) of other tobacco products (cigars)
• Household member already enrolled in the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Urge to Smoke - Pilot Testing	Post-cue presentation on Day 1, immediately following cue presentation	Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).
Urge to Smoke - AR Stimuli Session 2	Post-cue presentation on Day 1, immediately following cue presentation	Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).
Urge to Smoke - Testing AR Application	Up to Day 7 - Last Day of App Use, immediately following cue presentation	Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).
Urge to Smoke - AR Stimuli Session 1	Post-cue presentation on Day 1, immediately following cue presentation	Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).

Secondary Outcome Measures

Name	Time	Method
Reality/Co-Existence - Pilot Testing	Day 1, immediately following cue presentation	Three items will be used to assess the quality of the AR experience. Reality (How real did the object seem to you?) Environment Co-Existence (How well did the the object appear to be part of the scene?) and User Co-Existence (How much did you feel the object was right there in front of you?). These 3 items will be assessed using a 10 point Likert Scale from from 1 (Not at all) to 10 (Very much).
Reality/Co-Existence - AR Stimuli Session 1	Day 1, immediately following cue presentation	Three items will be used to assess the quality of the AR experience. Reality (How real did the object seem to you?) Environment Co-Existence (How well did the the object appear to be part of the scene?) and User Co-Existence (How much did you feel the object was right there in front of you?). These 3 items will be assessed using a 10 point Likert Scale from from 1 (Not at all) to 10 (Very much).
Reality/Co-Existence - AR Stimuli Session 2	Day 1, immediately following cue presentation	Three items will be used to assess the quality of the AR experience. Reality (How real did the object seem to you?) Environment Co-Existence (How well did the the object appear to be part of the scene?) and User Co-Existence (How much did you feel the object was right there in front of you?). These 3 items will be assessed using a 10 point Likert Scale from from 1 (Not at all) to 10 (Very much).

Trial Locations

Locations (1)

Moffitt Cancer Center; 🇺🇸 Tampa, Florida, United States